EH-APP

General Information


DRACP ID  DRACP01078

Peptide Name   EH-APP

Sequence  GEILCNLCTGLINTLENLLTTKGADKVKDYISSLCNKASGFIATLCTKVLDFGIDKLIQLIEDKVDANAICAKIHAC

Sequence Length  77

UniProt ID  Not available

PubChem CID  Not available

Origin  Entamoeba histolytica

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
U-937 Adult acute monocytic leukemi; Acute monoblastic/monocytic leukemia Leukemia LC50=80 µM Trypan blue assay 1h 1
Jurkat Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia Leukemia LC50=14 µM Trypan blue assay 1h 1

Hemolytic Activity  Human erythrocytes: 10% Hemolysis=10 µm

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01078

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys5<--->Cys77; Cys8<--->Cys71; Cys35<--->Cys46

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C362H605N93O112S6

Absent amino acids  MPRW

Common amino acids  L

Mass  960060

Pl  5.74

Basic residues  9

Acidic residues  9

Hydrophobic residues  32

Net charge  0

Boman Index  -4478

Hydrophobicity  40.65

Aliphatic Index  121.69

Half Life 
  Mammalian: 1.9 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  1865

Absorbance 280nm  24.54

Polar residues  26

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 8146160

Title  Cytolytic and antibacterial activity of synthetic peptides derived from amoebapore, the pore-forming peptide of Entamoeba histolytica

Doi 10.1073/pnas.91.7.2602

Year  1994

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.